Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 34.90p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.10p
  • 52 Week Low: 23.25p
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 0
  • Market Cap: £126.16m

Latest ShareCast News

Creo device used in 'groundbreaking' lung cancer procedure

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Creo Medical FY revenues up double digits

By Iain Gilbert

Date: Wednesday 07 Feb 2024

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Creo launches 'Speedboat Ultraslim' with first UK procedure

By Josh White

Date: Wednesday 13 Dec 2023

(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.

Creo Medical gets US FDA clearance for Speedboat... 01-Nov-2023 ShareCast
Creo Medical accelerating EU launch of Speedboat... 25-Oct-2023 ShareCast
Creo Medical's 'Speedboat Inject' used for first... 26-Jun-2023 ShareCast
Creo's Speedboat Inject to be evaluated by NICE 01-Jun-2023 ShareCast
Creo Medical achieves second Albyn earn-out target 14-Apr-2023 ShareCast
Creo raising at least £25m to progress various p... 16-Feb-2023 ShareCast
Creo Medical signs IP licence deal with CMR Surg... 24-Oct-2022 ShareCast
Creo Medical ends year with revenue above foreca... 03-Feb-2022 ShareCast
Creo Medical acquires Aber Electronics for undis... 12-Nov-2021 ShareCast
Creo Medical losses widen slightly as products p... 30-Sep-2021 ShareCast
Creo Medical opens new US headquarters as it foc... 16-Jul-2021 ShareCast
Creo Medical buys freehold on head office and ad... 06-Jul-2021 ShareCast
Creo upbeat on first in-human use of MicroBlate ... 16-Jun-2021 ShareCast
Creo Medical buying freehold of current Chepstow... 14-Jun-2021 ShareCast
Creo sales grow, losses widen as company expands 04-Jun-2021 ShareCast
Creo upbeat on new data around economics of 'Spe... 26-May-2021 ShareCast
Creo Medical ups FY revenues guidance after stro... 19-May-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 34.90p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.10p
52 Week Low 23.25p
Volume 0
Shares Issued 361.48m
Market Cap £126.16m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.45% below the market average21.45% below the market average21.45% below the market average21.45% below the market average21.45% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
10.06% above the market average10.06% above the market average10.06% above the market average10.06% above the market average10.06% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average
Income Not Available
Growth
43.08% above the market average43.08% above the market average43.08% above the market average43.08% above the market average43.08% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page